{"id":3062,"date":"2018-04-22T13:41:47","date_gmt":"2018-04-22T13:41:47","guid":{"rendered":"http:\/\/cardiologynownews.org\/?p=3062"},"modified":"2018-05-10T13:19:53","modified_gmt":"2018-05-10T18:19:53","slug":"blood-pressure-controlled-or-medication-adherence-what-say-smartphone","status":"publish","type":"post","link":"https:\/\/cardiologynownews.org\/?p=3062","title":{"rendered":"Smartphone App May Improve Medication Adherence in Hypertension"},"content":{"rendered":"

A new study published in the\u00a0Journal of American Medical Association<\/a><\/em>\u00a0finds that use of a smartphone app can result\u00a0in a small, but significant improvement in self-reported medication adherence, although it does\u00a0not affect blood pressure control in patients with hypertension.<\/p>\n

<\/p>\n

Half of the patients with uncontrolled hypertension do not adhere to their medications. About\u00a0 160 medication-adherence apps exist, but they have\u00a0not been evaluated on a large scale.\u00a0<\/b>Morawski et al. sought to\u00a0determine if the Medisafe smartphone app could improve self-reported medication adherence and blood pressure control.<\/p>\n

\"\"[perfectpullquote align=”full” bordertop=”false” cite=”” link=”” color=”” class=”” size=””]“The <\/strong>MedISAFE-<\/strong>BP trial is, to our knowledge, the first randomized clinical trial reporting the effect of a stand-alone mHealth platform to increase medication adherence and improve blood pressure control.” -Morawski et al.<\/strong>\u00a0[\/perfectpullquote]<\/p>\n

 <\/p>\n

Medication adherence Improvement Support App For Engagement\u2014Blood Pressure (MedISAFE\u00a0-BP) was a two-arm, randomized clinical trial in which 411\u00a0 subjects were enrolled for 6 months through an online format and were mailed\u00a0home blood pressure (BP) monitors. The participants included were\u00a018-75 years of age, having BP greater than 140\/90 mm Hg and less than 180\/120 mm Hg, and treated with\u00a0at least\u00a01, but not more\u00a0than 3 antihypertensive drugs. They were randomized at a ratio of 1:1. The\u00a08-item Morisky medication adherence scale (MMAS-8) was recorded in the smartphone app ‘Medisafe’ which recorded BP as per instructions and sent alerts when doses were missed for the intervention arm of 209 participants. The control arm (202) did not use the application. The participants\u00a0were followed at 4, 8, and\u00a012 weeks.<\/p>\n

The investigators found out that 90% of the intervention arm\u00a0participants actually completed\u00a0the study. The mean (SD) adherence by MMAS-8 was 6.0(1.8) at baseline and increased by 0.4(1.5) in the arm that used the group while it remained unchanged in the\u00a0control arm participants after 12 weeks of follow up.\u00a0Although there is a statistically significant improvement in adherence from the intervention, this small magnitude of change should not translate into significant improvement in blood pressure.\u00a0Also, there was no difference in change of blood pressures between both arms after 12 weeks of follow up.<\/p>\n

Dr. Morawski et al acknowledged that the results were not generalizable\u00a0as the recruitment was done using online\u00a0mechanisms. Home BP measurements were lower than in healthcare settings and the intervention could not be applied to those with blood pressure >180\/120 mm Hg. Since the trial was done for 12 weeks, it was not advisable to rely on longer outcomes\u00a0of a smartphone app.<\/p>\n

However, the investigators stressed on the importance of the trial, stating that “The\u00a0MedISAFE-BP trial is, to our knowledge, the first randomized\u00a0clinical trial reporting the effect of a stand-alone mHealth platform\u00a0to increase medication adherence and improve blood pressure control.”<\/p>\n

Source:\u00a0Association of a Smartphone Application With Medication Adherence and Blood Pressure Control<\/a>
\nThe MedISAFE-BP Randomized Clinical Trial, JAMA Intern Med.\u00a0<\/span>Published online April 16, 2018. doi:10.1001\/jamainternmed.2018.0447<\/span><\/p>\n

<\/div>\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

A new study published in the\u00a0Journal of American Medical Association\u00a0finds that use of a smartphone app can result\u00a0in a small, but significant improvement in self-reported medication adherence, although it does\u00a0not affect blood pressure control in patients with hypertension.<\/p>\n","protected":false},"author":38,"featured_media":3058,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12,169,8],"tags":[47],"ppma_author":[176],"class_list":{"0":"post-3062","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-cardiovascular-prevention","8":"category-hypertension","9":"category-news","10":"tag-featured","11":"author-cap-amandeep-singh"},"authors":[{"term_id":176,"user_id":0,"is_guest":1,"slug":"cap-amandeep-singh","display_name":"Amandeep Singh","avatar_url":"https:\/\/secure.gravatar.com\/avatar\/?s=96&r=g","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/3062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3062"}],"version-history":[{"count":36,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/3062\/revisions"}],"predecessor-version":[{"id":3544,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/posts\/3062\/revisions\/3544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=\/wp\/v2\/media\/3058"}],"wp:attachment":[{"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3062"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/cardiologynownews.org\/index.php?rest_route=%2Fwp%2Fv2%2Fppma_author&post=3062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}